口腔医学 ›› 2025, Vol. 45 ›› Issue (4): 268-274.doi: 10.13591/j.cnki.kqyx.2025.04.006

• 基础与临床研究 • 上一篇    下一篇

内皮细胞Tie2-L914F突变引发静脉畸形发病机制的初步研究

祁雨晨1, 黄佳栋2, 李天一3, 冷春儒1, 司亚萌3()   

  1. 1.徐州医科大学口腔医学院,江苏徐州(221004)
    2.靖江市人民医院口腔科,江苏泰州(214500)
    3.徐州医科大学附属口腔医院口腔颌面外科,江苏徐州(221002)
  • 收稿日期:2024-07-14 出版日期:2025-04-28 发布日期:2025-04-25
  • 通讯作者: 司亚萌, E-mail:1399773760@qq.com
  • 基金资助:
    徐州市科技重点研发计划项目(KC23223)

A preliminary study on the pathogenesis of venous malformations caused by Tie2-L914F mutations in endothelial cells

QI Yuchen1, HUANG Jiadong2, LI Tianyi3, LENG Chunru1, SI Yameng3()   

  1. College of Stomatology, Xuzhou Medical University, Xuzhou 221004, China
  • Received:2024-07-14 Online:2025-04-28 Published:2025-04-25

摘要:

目的 探究静脉畸形患者TEK受体酪氨酸激酶(TEK receptor tyrosine kinase,Tie2)L914F突变对血管内皮细胞的生物学行为影响及相关信号通路的变化。方法 基因测序检测静脉畸形中Tie2-L914F突变情况。运用HE染色及免疫组织化学染色检测该突变导致的静脉畸形组织中,血小板衍生生长因子亚基B(platelet derived growth factor subunit B,PDGFB)和α-平滑肌肌动蛋白(α-smooth muscle actin,α-SMA)的表达。将过表达Tie2野生型(Tie2-wild type,Tie2-WT)、Tie2-L914F和Tie2-GFP(green fluorescent protein,GFP)的慢病毒感染人脐静脉内皮细胞(human umbilical vein endothelial cells,HUVECs)。实时荧光定量PCR检测内皮细胞中Tie2的表达水平及蛋白质免疫印迹法检测Flag标签蛋白Tie2蛋白用于验证转染效率。通过CCK-8法、流式细胞术、Transwell迁移实验、Matrigel基质胶成管实验测定细胞的增殖、凋亡、迁移、成管能力,蛋白质免疫印迹法检测蛋白激酶B(protein kinase B,PKB/AKT)、FOXO1及其磷酸化表达水平,ELISA法检测PDGFB表达水平。结果 发生L914F位点突变的静脉畸形患者数量约为33.3%。HE及免疫组织化学染色显示:发生Tie2-L914F突变的静脉畸形组织中PDGFB及α-SMA表达显著下调,并与管壁细胞覆盖率下降呈正相关。与表达Tie2-WT内皮细胞比较,表达Tie2-L914F内皮细胞凋亡数明显减少,同时增殖及迁移能力显著增加,成管能力则显著下降。蛋白质免疫印迹及ELISA法显示:表达Tie2-L914F内皮细胞Tie2信号通路下游AKT及FOXO1磷酸化水平显著升高,PDGFB表达水平显著下降。结论 在静脉畸形中,Tie2-L914F突变可能通过AKT信号通路下调PDGFB表达,影响血管内皮细胞的生物学行为。

关键词: 静脉畸形, TEK受体酪氨酸激酶, AKT通路, Tie2-L914F突变

Abstract:

Objective To investigate the effects of TEK receptor tyrosine kinase (Tie2) L914F mutation on the biological behavior of vascular endothelial cells and the changes of related signaling pathways in patients with venous malformations. Methods Gene sequencing was used to detect Tie2-L914F mutations in venous malformations. HE staining and immunohistochemical staining were used to detect the expression of platelet derived growth factor subunit B gene (PDGFB) and α-smooth muscle actin (α-SMA) in venous malformations caused by the mutation. Lentivirus overexpressing Tie2-wild type (Tie2-WT), Tie2-L914F and Tie2-GFP (green fluorescent protein, GFP) infected human umbilical vein endothelial cells (HUVECs). Real-time fluorescence quantitative PCR was used to detect the expression level of Tie2 in endothelial cells expressing exogenous Tie2 and Flag-tagged protein Tie2 protein was detected by western blotting to verify transfection efficiency. The proliferation, apoptosis, migration and tube-forming ability of the cells were determined by CCK-8, flow cytometry, Transwell migration assay and Matrigel matrix gel tube-forming assay. Western blotting was used to detect the expression levels of Protein Kinase B (PKB/AKT), FOXO1 and their phosphorylation, and the expression level of PDGFB was detected by ELISA. Results The number of patients with venous malformations with L914F mutations was about 33.3%. HE and immunohistochemical staining showed that the expressions of PDGFB and α-SMA were significantly down-regulated in venous malformation tissues with Tie2-L914F mutation, and were positively correlated with the decrease in cell coverage of the tube wall. Compared with Tie2-WT endothelial cells, the apoptosis number of Tie2-L914F endothelial cells was significantly reduced, while the proliferation and migration ability was significantly increased, and the tube-forming ability was significantly decreased. Western blotting and ELISA showed that the phosphorylation levels of AKT and FOXO1 downstream of Tie2 signaling pathway in endothelial cells expressing Tie2-L914F were significantly increased, and the expression level of PDGFB was significantly decreased. Conclusion In venous malformations, Tie2-L914F mutation may downregulate the expression of PDGFB through AKT signaling pathway, which affects the biological behavior of vascular endothelial cells.

Key words: venous malformation, TEK receptor tyrosine kinase (Tie2), AKT pathway, Tie2-L914F mutations

中图分类号: